Alpha Crest Capital Management LLC Adaptive Biotechnologies Corp Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$6.4 - $14.73 $126,790 - $291,816
19,811 Added 42.83%
66,066 $534,000
Q1 2022

May 12, 2022
BUY
$10.12 - $28.9 $468,100 - $1.34 Million
46,255 New
46,255 $642,000
Q4 2021

Feb 09, 2022
SELL
$25.17 - $36.85 $175,736 - $257,286
-6,982 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$30.02 - $39.87 $270,720 - $359,547
-9,018 Reduced 56.36%
6,982 $237,000
Q2 2021

Aug 12, 2021
BUY
$32.22 - $44.59 $138,546 - $191,737
4,300 Added 36.75%
16,000 $654,000
Q1 2021

May 13, 2021
BUY
$37.26 - $67.74 $435,942 - $792,557
11,700 New
11,700 $471,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email